Trends in prevalence of depression and anxiety symptoms and effects of sociodemographic variables before and after the first wave of COVID-19 in Qatar

被引:4
作者
Khaled, Salma M. [1 ,2 ,3 ]
Davis, Veena [1 ]
Amro, Iman [1 ]
Ali, Amal A. M. [1 ]
Woodruff, Peter W. [4 ]
Haddad, Peter M. [5 ,6 ,7 ]
机构
[1] Qatar Univ, Social & Econ Survey Res Inst, SESRI, POB 2713, Doha, Qatar
[2] Qatar Univ, Coll Hlth Sci, Dept Publ Hlth, POB 2713, Doha, Qatar
[3] Qatar Univ, Coll Med, Dept Populat Med, POB 2713, Doha, Qatar
[4] Univ Sheffield Western Bank, Sch Med, Dept Neurosci, Sheffield S10 2TN, England
[5] Hamad Med Corp, POB 3050, Doha, Qatar
[6] Qatar Univ, Coll Med, Doha, Qatar
[7] Univ Manchester, Div Psychol & Mental Hlth, Manchester, England
关键词
COVID-19; Prevalence; Depression; Anxiety; PHQ-9; GAD-7; Qatar; Sociodemographic; Pre-first pandemic wave; Post-first pandemic wave; Trend analysis; PRIMARY-CARE; HEALTH; DISORDERS; VALIDITY; PHQ-9;
D O I
10.1016/j.jad.2022.04.019
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: Prevalence trends from Arabic speaking countries on psychiatric symptoms before and after the first wave of the COVID-19 pandemic are lacking. We estimated the point prevalence and change in depression and anxiety symptoms scores in relation to sociodemographic variables following the resolution of the first wave in Qatar compared with before the pandemic. Methods: We conducted a trend analysis using repeated nationally representative cross-sectional surveys spanning 2017, 2018, 2020/2021 and using the Patient Health Questionnaire-9 (PHQ-9) and Generalized Anxiety Disorder-7 (GAD-7) to assess depressive and anxiety symptoms. Negative binomial regression was used to model changes in these symptoms in relation sociodemographics and survey year. Results: The two-week prevalence of depressive symptoms (>10 on the PHQ-9) was 6.6% in 2017 and 6.5% in 2020/2021 (p = 0.986). The two-week prevalence of anxiety symptoms (>10 on the GAD-7) was 3.6% in 2018 and 5.1% in 2020/2021 (p = 0.062). The data for 2020/21 showed a 35.1% and 29.2% decrease in depression and anxiety symptoms scores compared to pre-pandemic years (2017/2018) after adjusting for sociodemographic factors. Limitations: Screening tools rather than structured interviews were used to assess depressive and anxiety symptoms Conclusions: The prevalence of depression and anxiety after the first COVID wave did not differ significantly to pre-pandemic estimates. The end of the first wave of the pandemic weakened the associations of these symptoms with traditional sociodemographic risk factors. The 2020/21 depression and anxiety symptoms scores remained high for Qataris and Arabs, suggesting that these cultural groups may benefit most from public mental health interventions.
引用
收藏
页码:412 / 421
页数:10
相关论文
共 50 条
  • [21] Prevalence and Potential Determinants of COVID-19 Vaccine Hesitancy and Resistance in Qatar: Results from a Nationally Representative Survey of Qatari Nationals and Migrants between December 2020 and January 2021
    Khaled, Salma M.
    Petcu, Catalina
    Bader, Lina
    Amro, Iman
    Al-Hamadi, Aisha Mohammed H. A.
    Al Assi, Marwa
    Ali, Amal Awadalla Mohamed
    Le Trung, Kien
    Diop, Abdoulaye
    Bellaj, Tarek
    Al-Thani, Mohamed H.
    Woodruff, Peter W.
    Alabdulla, Majid
    Haddad, Peter M.
    [J]. VACCINES, 2021, 9 (05)
  • [22] Prevalence and potential determinants of subthreshold and major depression in the general population of Qatar
    Khaled, Salma M.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2019, 252 : 382 - 393
  • [23] Anxiety disorders in primary care:: Prevalence, impairment, comorbidity, and detection
    Kroenke, Kurt
    Spitzer, Robert L.
    Williams, Janet B. W.
    Monahan, Patrick O.
    Lowe, Bernd
    [J]. ANNALS OF INTERNAL MEDICINE, 2007, 146 (05) : 317 - 325
  • [24] The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review
    Kroenke, Kurt
    Spitzer, Robert L.
    Williams, Janet B. W.
    Loewe, Bernd
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2010, 32 (04) : 345 - 359
  • [25] The PHQ-8 as a measure of current depression in the general population
    Kroenke, Kurt
    Strine, Tara W.
    Spitzer, Robert L.
    Williams, Janet B. W.
    Berry, Joyce T.
    Mokdad, Ali H.
    [J]. JOURNAL OF AFFECTIVE DISORDERS, 2009, 114 (1-3) : 163 - 173
  • [26] Mental burden and its risk and protective factors during the early phase of the SARS-CoV-2 pandemic: systematic review and meta-analyses
    Kunzler, Angela M.
    Roethke, Nikolaus
    Guenthner, Lukas
    Stoffers-Winterling, Jutta
    Tuescher, Oliver
    Coenen, Michaela
    Rehfuess, Eva
    Schwarzer, Guido
    Binder, Harald
    Schmucker, Christine
    Meerpohl, Joerg J.
    Lieb, Klaus
    [J]. GLOBALIZATION AND HEALTH, 2021, 17 (01)
  • [27] Depression, anxiety and somatization in primary care:: syndrome overlap and functional impairment
    Loewe, Bernd
    Spitzer, Robert L.
    Williams, Janet B. W.
    Mussell, Monika
    Schellberg, Dieter
    Kroenke, Kurt
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2008, 30 (03) : 191 - 199
  • [28] Long J. S., 2006, REGRESSION MODELS CA, V7
  • [29] Detecting and monitoring depression with a two-item questionnaire (PHQ-2)
    Löwe, B
    Kroenke, K
    Gräfe, K
    [J]. JOURNAL OF PSYCHOSOMATIC RESEARCH, 2005, 58 (02) : 163 - 171
  • [30] Validity of the Brief Patient Health Questionnaire Mood Scale (PHQ-9) in the general population
    Martin, A
    Rief, W
    Klaiberg, A
    Braehler, E
    [J]. GENERAL HOSPITAL PSYCHIATRY, 2006, 28 (01) : 71 - 77